{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:32:42Z","timestamp":1789115562423,"version":"build-2803163510"},"reference-count":60,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Individuals with intellectual and\/or developmental disability (IDD) are often prescribed antipsychotics (APs). However, despite their known propensity to cause metabolic adverse effects, including weight gain, diabetes, and increased risk of cardiovascular events, there is currently a limited body of literature describing the metabolic consequences of AP use in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE, EMBASE, PsychINFO, CENTRAL, and CINAHL databases to identify all randomized trials that reported on the metabolic effects of APs in individuals with IDD. Random effects meta\u2010analyses were used to examine weight gain as both a continuous and dichotomous outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighteen randomized trials met our inclusion criteria with a total of 1376 patients across a variety of IDDs. AP use was associated with significantly greater weight gain compared with placebo (Continuous: mean difference\u00a0= 1.10\u00a0kg, [0.79, 1.40],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u200954%; Dichotomous: odds ratio\u00a0=\u00a03.94, [2.15, 7.23],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u20090). Sub\u2010group analysis revealed no significant effect of AP type. Data regarding the effects of APs on other metabolic outcomes were limited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review (PROSPERO # CRD42021255558) demonstrates that AP use is associated with significant weight gain among patients with IDD. Concerningly, most reported studies were in children and adolescents, which sets up an already vulnerable population for adverse medical sequalae at an early age. There was also a lack of long\u2010term studies in adults with IDD. Further studies are required to better understand how AP use affects metabolic parameters in this group of individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/acps.13484","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T08:41:29Z","timestamp":1658911289000},"page":"201-214","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The metabolic adverse effects of antipsychotic use in individuals with intellectual and\/or developmental disability: A systematic review and\n                    <scp>meta\u2010analysis<\/scp>"],"prefix":"10.1111","volume":"146","author":[{"given":"Emily","family":"Smith","sequence":"first","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Stogios","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Au","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Department of Pharmacology University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Maksyutynska","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhita","family":"De","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ji","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Erlang S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Center for Neuropsychiatric Schizophrenia Research (CNSR) Mental Health Center Glostrup, Copenhagen University Hospital  Glostrup Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"St. John","sequence":"additional","affiliation":[{"name":"Azrieli Adult Neurodevelopmental Centre Centre for Addiction and Mental Health (CAMH)  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang\u2010Yuan","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Medical Science University of Toronto  Toronto Canada"},{"name":"Azrieli Adult Neurodevelopmental Centre Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpal","family":"Desarkar","sequence":"additional","affiliation":[{"name":"Institute of Medical Science University of Toronto  Toronto Canada"},{"name":"Azrieli Adult Neurodevelopmental Centre Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-9728","authenticated-orcid":false,"given":"Yona","family":"Lunsky","sequence":"additional","affiliation":[{"name":"Azrieli Adult Neurodevelopmental Centre Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-9416","authenticated-orcid":false,"given":"Gary","family":"Remington","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hahn","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"},{"name":"Department of Pharmacology University of Toronto  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"},{"name":"Banting and Best Diabetes Centre University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Mahavir","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Schizophrenia Division Centre for Addiction and Mental Health (CAMH)  Toronto Canada"},{"name":"Institute of Medical Science University of Toronto  Toronto Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Canada"},{"name":"Banting and Best Diabetes Centre University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.12927\/hcq.2014.24026"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717727240"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-019-03903-7"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028125"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2000.00307.x"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1617-6"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4326"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12471"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900465"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0003"},{"key":"e_1_2_11_12_1","volume-title":"Therapies for Children with Autism Spectrum Disorders","author":"Warren Z","year":"2011"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1445720"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.02.858"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12772"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jar.12190"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_11_18_1","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor DM","year":"2018"},{"key":"e_1_2_11_19_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 63","author":"Sch\u00fcnemann HJ","year":"2022"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2271"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2010.01352.x"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0620-5"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.7.633"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1337"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1723-5"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.575"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/08830738060210060801"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-0264-F"},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","unstructured":"BuitelaarJK van derGaagRJ MelmanCTM.Risperidone in the treatment of aggressive behaviour disorders in adolescents with mild mental retardation. A prospective randomised double\u2010blind placebo\u2010controlled trial. Conference Abstract;1998.","DOI":"10.1016\/S0924-977X(98)80578-6"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200209000-00002"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-016-0704-x"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76658"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3782"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.541"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-015-2628-x"},{"issue":"6","key":"e_1_2_11_37_1","first-page":"580","article-title":"Effects of thioridazine dosage on the behavior of severely mentally retarded persons","volume":"85","author":"Singh NN","year":"1981","journal-title":"Am J Ment Defic"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0405"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.974549"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.156"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2019.0087"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000435035.45308.03"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12417"},{"issue":"1","key":"e_1_2_11_44_1","first-page":"1","article-title":"Second\u2010generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer JW","year":"2005","journal-title":"CNS Drugs"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2015.12.2.242"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1820985"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30191-2"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1713091"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00222.x"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094112"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2923"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16040442"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1125"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119885918"},{"key":"e_1_2_11_55_1","first-page":"38","article-title":"Off\u2010label utilization of antipsychotics","volume":"9","author":"Zullino D","year":"2006","journal-title":"S Afr Psychiatr Rev"},{"key":"e_1_2_11_56_1","first-page":"e190013","article-title":"Preclinical and clinical sex differences in antipsychotic\u2010induced metabolic disturbances: a narrative review of adiposity and glucose metabolism","volume":"4","author":"Castellani LN","year":"2019","journal-title":"J Psychiatr Brain Sci"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803179"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-220"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.6.537"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1549"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700032"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acps.13484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/acps.13484","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acps.13484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T09:00:39Z","timestamp":1692694839000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acps.13484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/acps.13484"],"URL":"https:\/\/doi.org\/10.1111\/acps.13484","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/ACPS.13484\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/ACPS.13484\/v2\/decision1","asserted-by":"object"}]},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"2022-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}